Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells

British Journal of Pharmacology

Volumn 123, Issue 1, 1998, Pages 13-22

  Soares da Silva, P ^a   Serrao M P ^a   Vieira Coelho, M A ^a   Pestana, M ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Cyclosporine A; Dopamine; L DOPA; LLC PK1 cells; P glycoprotein

Indexed keywords

AMINE; BENSERAZIDE; COLLAGEN; CYCLOSPORIN A; DOPAMINE; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; LEVODOPA; PLASTIC; RHODAMINE 123; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DECARBOXYLATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BENSERAZIDE; BODY WATER; CALCIUM CHANNEL BLOCKERS; CELL SURVIVAL; CYCLOSPORINE; DECARBOXYLATION; DOPAMINE; DOPAMINE AGENTS; LEVODOPA; LLC-PK1 CELLS; P-GLYCOPROTEIN; SWINE; VERAPAMIL;

EID: 0031974168     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701572     Document Type: Article

References (23)

1. BRADFORD, M.M. (1976). A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
2. DAWSON, R. Jr. & PHILLIPS, M.I. (1990). Dopamine synthesis and release in LLC-PK1 cells. Eur. J. Pharmacol., 189, 423-426.
3. DUTT, A., PRIEBE, T.S., TEETER, L.D., KUO, M.T. & NELSON, J.A. (1992). Postnatal development of organic cation transport and MDR gene expression in mouse kidney. J. Pharmacol. Exp. Ther., 261, 1222-1230.
4. ENDICOTT, J.A. & LING, V. (1989). The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann. Rev. Biochem., 58, 137-171.
5. FARDEL, O., LECUREUR, V., CORLU, A. & GUILLOUZO, A. (1996). P-Glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem. Pharmacol., 51, 1427-1436.
6. FORD, J.M. & HAIT, W.N. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42, 155-199.
7. FOXWELL, B.M.J., MACKIE, A., LINGAND, V. & RYFFEL, B. (1989). Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol. Pharmacol., 36, 543-546.
8. GARCIA DEL MORAL, R.F.O.V., ANDUJAR, M., AGUILAR, M., LUCENA, M.A., LOPEZ-HIDALGO, J., RAMIREZ, C., MEDINACANO, M.T., AGUILAR, D. & GOMEZ-MORALES, M. (1995). Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study. Am. J. Pathol., 146, 398-408.
9. GRENADER, A. & HEALY, D.P. (1991). Locally formed dopamine stimulates cAMP accumulation in LLC-PK1 cells via a DA1 dopamine receptor. Am. J. Physiol., 260, F906-F912.
10. 1. In Vitro, 12, 670-677.
11. KELLER, R.P., ALTERMATT, H.J., NOOTER, K., POSCHMANN, G., LAISSUE, J.A., BOLLINGER, P. & HIESTAND, P.C. (1992). SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia. Int. J. Cancer, 50, 593-597.
12. LEVEQUE, D. & JEHL, F. (1995). P-glycoprotein and pharmacokinetics. Anticancer Res., 15, 331-336.
13. MECHETNER, E.B. & RONINSON, I.B. (1992). Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A., 89, 5824-5828.
14. MOTULSKY, H.J., SPANNARD, P.& NEUBIG, R. (1994). GraphPad Prism (version 1.0). San Diego, U.S.A. GraphPad Prism Software Inc.
15. PESTANA, M., VIEIRA-COELHO, M.A., PINTO-DO-Ó, P.C., FERNANDES, M.H. & SOARES-DA-SILVA, P. (1995). Assessment of renal dopaminergic system activity during cyclosporin A administration in the rat. Br. J. Pharmacol., 115, 1349-1358.
16. PINTO-DO-Ó, P.C. & SOARES-DA-SILVA, P. (1996). Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules. Br. J. Pharmacol., 118, 741-747.
17. RAO, U.S. (1995). Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells. J. Biol. Chem., 270, 6686-6690.
18. SAEKI, T., UEDA, K., TANIGAWARA, Y., HORI, R. & KOMANO, T. (1993). Human P-glycoprotein transports cyclosporin A and FK506. J. Biol. Chem., 268, 6077-6080.
19. SOARES-DA-SILVA, P. (1993a). Kinetic study of the tubular dopamine outward transporter in the rat and dog kidney. Br. J. Pharmacol., 109, 577-580.
20. 2-adrenoceptor agonists. Br. J. Pharmacol., 109, 569-576.
21. SOARES-DA-SILVA, P., FERNANDES, M.H. & PINTO-DO-Ó, P.C. (1994). Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br. J. Pharmacol., 112, 611-615.
22. SOARES-DA-SILVA, P., SERRÃO, P. & VIEIRA-COELHA, M.A. (1996). A comparative study on the synthesis of the natriuretic hormone dopamine in OK and LLC-PK1 cells. Cell Biol. Int., 20, 539-544.
23. TWENTYMAN, P.R. (1992). Cyclosporins as drug resistance modifiers. Biochem. Pharmacol., 43, 109- 117.